OLFOX-4 regimen or single-agent gemcitabine as first-line chemotherapy in advanced biliary tract cancer.
Autori:
Novarino AM, Satolli MA, Chiappino I, Giacobino A, Napoletano R, Ceccarelli M, Ciccone G, Schena M, Bertetto O, Ciuffreda L.
Rivista:
Am J Clin Oncol 2013; 36: 466-71. doi: 10.1097/COC.0b013e31825691c3.